Suzhou Erye Pharmaceutical Co., Ltd
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference 9bc228c920
Drug names38First applicant · distinct drug namesAcceptance records70First applicant · distinct acceptance numbersUnder-review numbers11First applicant · current under-review listCo-applicant records45Subsequent applicant only · separate count
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/12 06:41.
Drug filings
70 acceptance records as first applicant, grouped into 38 source drug names. Source data as of 2026/11/12 06:41.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Dalteparin Sodium Injection 2 records · Latest accepted 2026/10/26
Generic · 2
复方聚乙二醇电解质散(儿童型) · No verified English name 1 records · Latest accepted 2026/05/12
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600901 | Supplement | 2026/05/12 | Suzhou Erye Pharmaceutical Co., Ltd; Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Cefcapene Pivoxil Hydrochloride Granules 1 records · Latest accepted 2026/03/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600738 | Generic | 2026/03/28 | Suzhou Erye Pharmaceutical Co., Ltd; Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CDE ↗ |
Omeprazole Sodium for Injection 1 records · Latest accepted 2026/02/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600415 | Supplement | 2026/02/28 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
Erythromycin Lactobionate for Injection 2 records · Latest accepted 2025/12/30
Generic · 2
Cefditoren Pivoxil Granules 2 records · Latest accepted 2025/12/19
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504329 | Generic | 2025/12/19 | Suzhou Erye Pharmaceutical Co., Ltd; Qi Lu An Ti Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2504328 | Generic | 2025/12/19 | Suzhou Erye Pharmaceutical Co., Ltd; Qi Lu An Ti Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Heparin Sodium Injection 2 records · Latest accepted 2025/12/03
Generic · 2
Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution 1 records · Latest accepted 2025/11/22
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2502386 | Supplement | 2025/11/22 | Suzhou Erye Pharmaceutical Co., Ltd; Huayi Pharmaceuticals (Anhui) Co., Ltd. | CDE ↗ |
Flomoxef Sodium for Injection 2 records · Latest accepted 2025/09/17
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503437 | Generic | 2025/09/17 | Suzhou Erye Pharmaceutical Co., Ltd; Chongqing Ji Si Rui Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2503436 | Generic | 2025/09/17 | Suzhou Erye Pharmaceutical Co., Ltd; Chongqing Ji Si Rui Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Linaclotide Capsules 1 records · Latest accepted 2025/06/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502007 | Generic | 2025/06/06 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
Sulbactam Sodium For Injection 1 records · Latest accepted 2025/04/25
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500823 | Supplement | 2025/04/25 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
注射用盐酸地尔硫? · No verified English name 1 records · Latest accepted 2025/02/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550103 | Supplement | 2025/02/10 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
Lactulose Oral Solution 2 records · Latest accepted 2025/01/27
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500229 | Supplement | 2025/01/27 | Suzhou Erye Pharmaceutical Co., Ltd; Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2500228 | Supplement | 2025/01/27 | Suzhou Erye Pharmaceutical Co., Ltd; Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Cefotaxime Sodium For Injection 3 records · Latest accepted 2024/09/26
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450498 | Supplement | 2024/09/26 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| CYHB2450497 | Supplement | 2024/09/26 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| CYHB2450496 | Supplement | 2024/09/26 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
Morinidazole and Sodium Chloride Injection 1 records · Latest accepted 2024/08/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402507 | Generic | 2024/08/07 | Suzhou Erye Pharmaceutical Co., Ltd; Jiangsu Chang Jiang Pharma Co., Ltd. romanized | CDE ↗ |
Ceftriaxone Sodium for Injection 4 records · Latest accepted 2024/07/04
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400982 | Supplement | 2024/07/04 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| CYHB2400981 | Supplement | 2024/07/04 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| CYHB2400980 | Supplement | 2024/07/04 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| CYHB2400979 | Supplement | 2024/07/04 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
磷霉素氨丁三醇颗粒 · No verified English name 1 records · Latest accepted 2024/01/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400128 | Generic | 2024/01/10 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
注射用头孢唑肟钠 · No verified English name 3 records · Latest accepted 2023/11/28
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350884 | Supplement | 2023/11/28 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| CYHB2350883 | Supplement | 2023/11/28 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| CYHB2350882 | Supplement | 2023/11/28 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
Ceftazidime for Injection 3 records · Latest accepted 2023/11/22
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350861 | Supplement | 2023/11/22 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| CYHB2350860 | Supplement | 2023/11/22 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| CYHB2350859 | Supplement | 2023/11/22 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
Cefoxitin Sodium for Injection 2 records · Latest accepted 2023/10/21
Supplement · 2
Cefuroxime Sodium for Injection 2 records · Latest accepted 2023/09/27
Supplement · 2
Cefazolin Sodium for Injection 2 records · Latest accepted 2023/09/21
Supplement · 2
Linezolid and Glucose Injection 2 records · Latest accepted 2023/07/27
Supplement · 2
Ceftazidime And Avibactam Sodium For Injection 1 records · Latest accepted 2023/07/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301942 | Generic | 2023/07/20 | Suzhou Erye Pharmaceutical Co., Ltd; Qi Lu An Ti Pharmaceutical Co., Ltd. romanized | CDE ↗ |
注射用SZEY-2108 · No verified English name 1 records · Latest accepted 2023/03/28
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2300338 | New drug | 2023/03/28 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
Enoxaparin Sodium Injection 2 records · Latest accepted 2023/03/24
Supplement · 1Generic · 1
Ampicillin Sodium and Sulbactam Sodium for Injection 6 records · Latest accepted 2023/03/07
Supplement · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350233 | Supplement | 2023/03/07 | Suzhou Erye Pharmaceutical Co., Ltd; Shandong Er Ye Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2350232 | Supplement | 2023/03/06 | Suzhou Erye Pharmaceutical Co., Ltd; Shandong Er Ye Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2350231 | Supplement | 2023/03/06 | Suzhou Erye Pharmaceutical Co., Ltd; Shandong Er Ye Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2350045 | Supplement | 2023/01/12 | Suzhou Erye Pharmaceutical Co., Ltd; Shandong Er Ye Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2350044 | Supplement | 2023/01/12 | Suzhou Erye Pharmaceutical Co., Ltd; Shandong Er Ye Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2350043 | Supplement | 2023/01/12 | Suzhou Erye Pharmaceutical Co., Ltd; Shandong Er Ye Pharmaceutical Co., Ltd. romanized | CDE ↗ |
利福昔明片 · No verified English name 1 records · Latest accepted 2023/03/03
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300452 | Supplement | 2023/03/03 | Suzhou Erye Pharmaceutical Co., Ltd; Tianjin Jun An Biopharmaceutical Co., Ltd. romanized | CDE ↗ |
Lidocaine and Prilocaine Cream 1 records · Latest accepted 2023/02/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300566 | Generic | 2023/02/18 | Suzhou Erye Pharmaceutical Co., Ltd; Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CDE ↗ |
复方匹可硫酸钠颗粒 · No verified English name 1 records · Latest accepted 2023/02/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300519 | Generic | 2023/02/14 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
Oxacillin Sodium for Injection 3 records · Latest accepted 2023/02/03
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350135 | Supplement | 2023/02/03 | Suzhou Erye Pharmaceutical Co., Ltd; Shandong Er Ye Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2350134 | Supplement | 2023/02/03 | Suzhou Erye Pharmaceutical Co., Ltd; Shandong Er Ye Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2350133 | Supplement | 2023/02/03 | Suzhou Erye Pharmaceutical Co., Ltd; Shandong Er Ye Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Ampicillin Sodium For Injection 3 records · Latest accepted 2022/10/14
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250640 | Supplement | 2022/10/14 | Suzhou Erye Pharmaceutical Co., Ltd; Shandong Er Ye Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2250639 | Supplement | 2022/10/14 | Suzhou Erye Pharmaceutical Co., Ltd; Shandong Er Ye Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2250638 | Supplement | 2022/10/14 | Suzhou Erye Pharmaceutical Co., Ltd; Shandong Er Ye Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Piperacillin Sodium for Injection 2 records · Latest accepted 2022/08/25
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250534 | Supplement | 2022/08/25 | Suzhou Erye Pharmaceutical Co., Ltd; Shandong Er Ye Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2250533 | Supplement | 2022/08/25 | Suzhou Erye Pharmaceutical Co., Ltd; Shandong Er Ye Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Rivaroxaban Tablets 1 records · Latest accepted 2021/11/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101954 | Generic | 2021/11/01 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
Piperacillin Sodium And Tazobactam Sodium For Injection 3 records · Latest accepted 2021/08/26
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150821 | Supplement | 2021/08/26 | Suzhou Erye Pharmaceutical Co., Ltd; Shandong Er Ye Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2150820 | Supplement | 2021/08/26 | Suzhou Erye Pharmaceutical Co., Ltd; Shandong Er Ye Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2150819 | Supplement | 2021/08/26 | Suzhou Erye Pharmaceutical Co., Ltd; Shandong Er Ye Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Bivalirudin for Injection 1 records · Latest accepted 2021/07/30
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2101646 | Supplement | 2021/07/30 | Suzhou Erye Pharmaceutical Co., Ltd; Hainan Shuang Cheng Pharma Co., Ltd. romanized | CDE ↗ |
EY-1936注射液 · No verified English name 1 records · Latest accepted 2021/03/16
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2100185 | New drug | 2021/03/16 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
Oseltamivir Phosphate For Oral Suspension 1 records · Latest accepted 2021/01/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100038 | Generic | 2021/01/11 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
Changes in the last 90 days
2 events from 2026/08/15 to 2026/11/12. CDE data as of 2026/11/12 06:41; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Accepted: 2 applications
- 2026/10/26Accepted
Dalteparin Sodium Injection
CYHS2602619
Fact date: 2026/10/26 · Site observation date: 2026/10/27
View source ↗ - 2026/10/26Accepted
Dalteparin Sodium Injection
CYHS2602618
Fact date: 2026/10/26 · Site observation date: 2026/10/27
View source ↗
Under review
11 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/12 06:41.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Dalteparin Sodium Injection | CYHS2602619 | Generic | 2026/10/26 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Dalteparin Sodium Injection | CYHS2602618 | Generic | 2026/10/26 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Cefcapene Pivoxil Hydrochloride Granules | CYHS2600738 | Generic | 2026/03/28 | Suzhou Erye Pharmaceutical Co., Ltd; Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CDE ↗ |
| Erythromycin Lactobionate for Injection | CYHS2504472 | Generic | 2025/12/30 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Erythromycin Lactobionate for Injection | CYHS2504471 | Generic | 2025/12/30 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Cefditoren Pivoxil Granules | CYHS2504329 | Generic | 2025/12/19 | Suzhou Erye Pharmaceutical Co., Ltd; Qi Lu An Ti Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Cefditoren Pivoxil Granules | CYHS2504328 | Generic | 2025/12/19 | Suzhou Erye Pharmaceutical Co., Ltd; Qi Lu An Ti Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Heparin Sodium Injection | CYHS2504145 | Generic | 2025/12/03 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Flomoxef Sodium for Injection | CYHS2503437 | Generic | 2025/09/17 | Suzhou Erye Pharmaceutical Co., Ltd; Chongqing Ji Si Rui Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Flomoxef Sodium for Injection | CYHS2503436 | Generic | 2025/09/17 | Suzhou Erye Pharmaceutical Co., Ltd; Chongqing Ji Si Rui Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Linaclotide Capsules | CYHS2502007 | Generic | 2025/06/06 | Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
Catalogue holder records
50 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/12 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 复方聚乙二醇(3350)电解质散 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | 国药准字H20265407 | 2026/07/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Morinidazole and Sodium Chloride Injection | Suzhou Erye Pharmaceutical Co., Ltd | Jiangsu Chang Jiang Pharma Co., Ltd. romanized | 国药准字H20263892 | 2026/04/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 注射用盐酸地尔硫? · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20054659 | 2026/02/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefotaxime Sodium For Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H32021317 | 2025/10/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefotaxime Sodium For Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H32021318 | 2025/10/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefotaxime Sodium For Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H32021319 | 2025/10/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 复方匹可硫酸钠颗粒 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20253426 | 2025/02/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ceftazidime for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20023064 | 2024/12/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftazidime for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20033007 | 2024/12/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftazidime for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20023063 | 2024/12/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftazidime And Avibactam Sodium For Injection | Suzhou Erye Pharmaceutical Co., Ltd | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized | 国药准字H20249702 | 2024/12/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 注射用头孢唑肟钠 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20060339 | 2024/11/08 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoxitin Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20057943 | 2024/11/08 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoxitin Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20057942 | 2024/11/08 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 注射用头孢唑肟钠 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20060338 | 2024/11/08 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefazolin Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H32021315 | 2024/09/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefazolin Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H32021316 | 2024/09/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefuroxime Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20063777 | 2024/09/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefuroxime Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20063779 | 2024/09/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ampicillin Sodium and Sulbactam Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Shandong Er Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20013127 | 2024/03/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ampicillin Sodium and Sulbactam Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Shandong Er Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20033155 | 2024/03/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ampicillin Sodium and Sulbactam Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Shandong Er Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20013126 | 2024/03/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Oxacillin Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Shandong Er Ye Pharmaceutical Co., Ltd. romanized | 国药准字H32021313 | 2024/01/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Oxacillin Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Shandong Er Ye Pharmaceutical Co., Ltd. romanized | 国药准字H32021314 | 2024/01/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Oxacillin Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Shandong Er Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20247017 | 2024/01/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Enoxaparin Sodium Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20247014 | 2024/01/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Piperacillin Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Shandong Er Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20043464 | 2023/09/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Piperacillin Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Shandong Er Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20043580 | 2023/09/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ampicillin Sodium For Injection | Suzhou Erye Pharmaceutical Co., Ltd | Shandong Er Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20043165 | 2023/08/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ampicillin Sodium For Injection | Suzhou Erye Pharmaceutical Co., Ltd | Shandong Er Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20043164 | 2023/08/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ampicillin Sodium For Injection | Suzhou Erye Pharmaceutical Co., Ltd | Shandong Er Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20237098 | 2023/08/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Enoxaparin Sodium Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20223859 | 2022/11/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Piperacillin Sodium And Tazobactam Sodium For Injection | Suzhou Erye Pharmaceutical Co., Ltd | Shandong Er Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20073415 | 2022/11/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Piperacillin Sodium And Tazobactam Sodium For Injection | Suzhou Erye Pharmaceutical Co., Ltd | Shandong Er Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20073413 | 2022/11/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Rivaroxaban Tablets | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20223642 | 2022/08/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oseltamivir Phosphate For Oral Suspension | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20223568 | 2022/08/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rivaroxaban Tablets | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20223253 | 2022/04/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rivaroxaban Tablets | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20223254 | 2022/04/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20023062 | 2022/03/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20033247 | 2022/03/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20054656 | 2022/03/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefminox Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20073998 | 2021/12/14 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefminox Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20073999 | 2021/12/14 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Amoxicillin Sodium and Clavulanate Potassium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20033519 | 2021/11/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftriaxone Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20043086 | 2021/11/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftriaxone Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20033062 | 2021/11/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftriaxone Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20043864 | 2021/11/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftriaxone Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20023061 | 2021/11/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Amoxicillin Sodium and Clavulanate Potassium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20045122 | 2021/10/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Omeprazole Sodium for Injection | Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20056143 | 2021/07/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
23 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/12 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 达肝素钠 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20260000770 | I | 2026/09/07 | CDE ↗ |
| 丁苯酞 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20220001215 | A | 2025/07/04 | CDE ↗ |
| 匹可硫酸钠 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20210000844 | A | 2025/10/11 | CDE ↗ |
| 丙胺卡因 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20200001326 | A | 2024/06/27 | CDE ↗ |
| 肝素钠 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20200001340 | A | 2025/07/04 | CDE ↗ |
| 利伐沙班 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20190021442 | A | 2023/08/01 | CDE ↗ |
| 阿德福韦酯 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20190008317 | A | 2024/03/27 | CDE ↗ |
| 硫普罗宁 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20190008236 | A | — | CDE ↗ |
| 维库溴铵 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20190007302 | A | — | CDE ↗ |
| 青霉素钾 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20190006732 | A | — | CDE ↗ |
| 奥扎格雷 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20190006727 | A | — | CDE ↗ |
| 盐酸曲美他嗪 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20190006726 | A | — | CDE ↗ |
| 青霉素钠 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20190006725 | A | — | CDE ↗ |
| 葡萄糖酸依诺沙星 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20190004028 | A | 2025/06/21 | CDE ↗ |
| 乙酰螺旋霉素 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20190004027 | A | 2025/06/28 | CDE ↗ |
| 扎来普隆 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20190004024 | A | 2025/06/13 | CDE ↗ |
| 依诺肝素钠 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20190001423 | A | 2026/01/06 | CDE ↗ |
| 磺苄西林钠 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20190000313 | I | 2024/03/27 | CDE ↗ |
| 盐酸伊达比星 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20170001184 | I | — | CDE ↗ |
| 他唑巴坦钠 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20170000822 | A | 2026/06/10 | CDE ↗ |
| 恩替卡韦 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20170000532 | I | — | CDE ↗ |
| 盐酸乐卡地平 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20170000468 | I | — | CDE ↗ |
| 地氯雷他定 · No verified English name | Suzhou Erye Pharmaceutical Co., Ltd | Y20170000005 | I | — | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
45 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/12 06:41.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Deferasirox Tablets | CYHB2601660 | Supplement | 2026/08/31 | Fu Xing Wan Bang (Jiangsu) Pharmaceuticals Group Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Deferasirox Tablets | CYHB2601659 | Supplement | 2026/08/31 | Fu Xing Wan Bang (Jiangsu) Pharmaceuticals Group Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Deferasirox Granules | CYHB2601658 | Supplement | 2026/08/31 | Fu Xing Wan Bang (Jiangsu) Pharmaceuticals Group Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用磷酸左奥硝唑酯二钠 · No verified English name | CYHS2601773 | Generic | 2026/07/23 | Hua Bei Pharmaceutical Group Xin Yao Research Kai Fa Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Apalutamide Tablets | CYHS2600896 | Generic | 2026/04/18 | Shenyang Hong Qi Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用头孢噻吩钠 · No verified English name | CYHB2501973 | Supplement | 2025/10/10 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用头孢噻吩钠 · No verified English name | CYHB2501972 | Supplement | 2025/10/10 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用头孢噻吩钠 · No verified English name | CYHB2501971 | Supplement | 2025/10/10 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用硫酸头孢匹罗 · No verified English name | CYHB2501848 | Supplement | 2025/09/19 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用硫酸头孢匹罗 · No verified English name | CYHB2501847 | Supplement | 2025/09/19 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Cefoperazone Sodium For Injection | CYHB2501610 | Supplement | 2025/08/12 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Cefoperazone Sodium For Injection | CYHB2501609 | Supplement | 2025/08/12 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Cefoperazone Sodium For Injection | CYHB2501608 | Supplement | 2025/08/12 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Cefoperazone Sodium For Injection | CYHB2501607 | Supplement | 2025/08/12 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Cefoperazone Sodium For Injection | CYHB2501606 | Supplement | 2025/08/12 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用头孢唑肟钠 · No verified English name | CYHB2501474 | Supplement | 2025/07/24 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用头孢唑肟钠 · No verified English name | CYHB2501473 | Supplement | 2025/07/24 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用头孢唑肟钠 · No verified English name | CYHB2501472 | Supplement | 2025/07/24 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用盐酸头孢吡肟 · No verified English name | CYHB2500694 | Supplement | 2025/04/07 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用头孢匹胺钠 · No verified English name | CYHB2500693 | Supplement | 2025/04/07 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用头孢哌酮钠他唑巴坦钠(III) · No verified English name | CYHB2500692 | Supplement | 2025/04/07 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用头孢哌酮钠他唑巴坦钠(I) · No verified English name | CYHB2500691 | Supplement | 2025/04/07 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用头孢哌酮钠他唑巴坦钠(I) · No verified English name | CYHB2500690 | Supplement | 2025/04/07 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Sulbactam Sodium For Injection | CYHB2500617 | Supplement | 2025/03/26 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Cefminox Sodium for Injection | CYHB2500616 | Supplement | 2025/03/26 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Cefminox Sodium for Injection | CYHB2500615 | Supplement | 2025/03/26 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Polymyxin B sulfate for Injection | CYHS2500394 | Generic | 2025/01/22 | Gui Lin Nan Yao Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Isavuconazonium Sulfate for Injection | CYHS2500348 | Generic | 2025/01/17 | Gui Lin Nan Yao Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Apalutamide Tablets | CYHS2500251 | Generic | 2025/01/11 | Shenyang Hong Qi Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Cefamandole Nafate for Injection | CYHB2402216 | Supplement | 2024/12/25 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Cefamandole Nafate for Injection | CYHB2402215 | Supplement | 2024/12/25 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Cefamandole Nafate for Injection | CYHB2402214 | Supplement | 2024/12/25 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用头孢尼西钠 · No verified English name | CYHB2402189 | Supplement | 2024/12/21 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用头孢尼西钠 · No verified English name | CYHB2402188 | Supplement | 2024/12/21 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Deferasirox Tablets | CYHS2401014 | Generic | 2024/04/04 | Shanghai Fu Xing Pharmaceuticals Industry Development Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Deferasirox Tablets | CYHS2401013 | Generic | 2024/04/04 | Shanghai Fu Xing Pharmaceuticals Industry Development Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Deferasirox Granules | CYHS2400968 | Generic | 2024/03/29 | Shanghai Fu Xing Pharmaceuticals Industry Development Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用青霉素钾 · No verified English name | CYHB2301836 | Supplement | 2023/08/18 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用青霉素钾 · No verified English name | CYHB2301835 | Supplement | 2023/08/18 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用青霉素钾 · No verified English name | CYHB2301834 | Supplement | 2023/08/18 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用青霉素钾 · No verified English name | CYHB2301833 | Supplement | 2023/08/18 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| 注射用头孢唑肟钠 · No verified English name | CYHB2301214 | Supplement | 2023/05/26 | Shandong Er Ye Pharmaceutical Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Ganirelix Injection | CYHS2201339 | Generic | 2022/08/19 | Nanjing Kang Zhou Pharmaceuticals Technology Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Carbetocin Injection | CYHS2101472 | Generic | 2021/07/26 | Nanjing Kang Zhou Pharmaceuticals Technology Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
| Sivelestat Sodium for Injection | CYHB2100247 | Supplement | 2021/02/11 | Shanghai Hui Lun Jiangsu Pharma Co., Ltd. romanized; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/12 06:41
- Chemical-drug catalogue
- Last successful update: 2026/11/12 06:38
- Full API register
- Last successful update: 2026/11/12 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.